Skip to main content

Peptide Vaccine Against Paracoccidioidomycosis

  • Protocol
  • First Online:
Vaccines for Invasive Fungal Infections

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1625))

Abstract

The chapter reviews methods utilized for the isolation and characterization of a promising immunogen candidate, aiming at a human vaccine against paracoccidioidomycosis. Peptide P10 carries a T-CD4+ epitope and was identified as an internal sequence of the major diagnostic antigen known as gp43 glycoprotein. It successfully treated massive intratracheal infections by virulent Paracoccidioides brasiliensis in combination with chemotherapy.

An introduction about the systemic mycosis was found essential to understand the various options that were considered to design prophylactic and therapeutic vaccine protocols using peptide P10.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Theodoro RC, Teixeira MM, Felipe MSS et al (2012) Genus Paracoccidioides: species recognition and biogeographic aspects. PLoS One 7(5):e37694

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Teixeira MM, Theodoro RC, Nino-Vega G et al (2014) Paracoccidioides species complex: ecology, phylogeny, sexual reproduction, and virulence. PLoS Pathog 10(10):e1004397

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bocca AL, Amaral AC, Teixeira MM et al (2013) Paracoccidioidomycosis: eco-epidemiology, taxonomy and clinical and therapeutic issues. Future Microbiol 8(9):1177–1191

    Article  PubMed  Google Scholar 

  4. Taborda CP, Urán ME, Nosanchuk JD et al (2015) Paracoccidioidomycosis: challenges in the development of a vaccine against an endemic mycosis in the Americas. Rev do Inst Med Trop São Paulo 57(Suppl 19):21–24

    Article  Google Scholar 

  5. Prado M, Silva MB, Laurenti R et al (2009) Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz 104(3):513–521

    Article  PubMed  Google Scholar 

  6. Restrepo AM (1985) The ecology of Paracoccidioides brasiliensis: a puzzle still unsolved. Sabouraudia 23(5):323–334

    Article  CAS  PubMed  Google Scholar 

  7. Oliveira HC, Assato PA, Marcos CM et al (2015) Paracoccidioides-host interaction: an overview on recent advances in the paracoccidioidomycosis. Front Microbiol 6:1319

    PubMed  PubMed Central  Google Scholar 

  8. Wanke B, Aidê MA (2009) Chapter 6 - paracoccidioidomycosis. J Bras Pneumol 35(12):1245–1249

    Article  PubMed  Google Scholar 

  9. Stover EP, Schar G, Clemons KV et al (1986) Estradiol-binding proteins from mycelial and yeast-form cultures of Paracoccidioides brasiliensis. Infect Immun 51(1):199–203

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Loose DS, Stover EP, Restrepo A et al (1983) Estradiol binds to a receptor-like cytosol binding protein and initiates a biological response in Paracoccidioides brasiliensis. Proc Natl Acad Sci U S A 80(24):7659–7663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Franco M (1987) Host-parasite relationships in paracoccidioidomycosis. J Med Vet Mycol 25(1):5–18

    Article  CAS  PubMed  Google Scholar 

  12. Shikanai-Yasuda MA, Telles Filho FDQ, Mendes RP et al (2006) Consenso em paracoccidioidomicose. Rev Soc Bras Med Trop 39(3):297–310

    Article  PubMed  Google Scholar 

  13. Shikanai-Yasuda MA (2015) Paracoccidioidomycosis treatment. Rev Inst Med Trop São Paulo 57(Suppl 19):31–37

    Article  PubMed  PubMed Central  Google Scholar 

  14. Tobón AM, Agudelo CA, Osorio ML et al (2003) Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis 37(7):898–904

    Article  PubMed  Google Scholar 

  15. MJS M-G, Monteiro da Silva JL, Fátima da Silva J et al (2008) Interactions of Paracoccidioides brasiliensis with host cells: recent advances. Mycopathologia 165(4–5):237–248

    Google Scholar 

  16. Benard G (2008) An overview of the immunopathology of human paracoccidioidomycosis. Mycopathologia 165(4–5):209–221

    Article  CAS  PubMed  Google Scholar 

  17. Camargo ZP, Franco MF (2000) Current knowledge on pathogenesis and immunodiagnosis of paracoccidioidomycosis. Rev Iberoam Micol 17(2):41–48

    PubMed  Google Scholar 

  18. Marques SA (2012) Paracoccidioidomycosis. Clin Dermatol 30(6):610–615

    Article  PubMed  Google Scholar 

  19. Martinez R (2015) Epidemiology of paracoccidioidomycosis. Rev Inst Med Trop São Paulo 57(Suppl 19):11–20

    Article  PubMed  PubMed Central  Google Scholar 

  20. Travassos LR, Taborda CP, Colombo AL (2008) Treatment options for paracoccidioidomycosis and new strategies investigated. Expert Rev Anti-Infect Ther 6(2):251–262

    Article  CAS  PubMed  Google Scholar 

  21. Fries BC, Taborda CP, Serfass E et al (2001) Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 108(11):1639–1648

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Taborda CP, Rivera J, Zaragoza O et al (2003) More is not necessarily better: prozone-like effects in passive immunization with IgG. J Immunol 170(7):3621–3630

    Article  CAS  PubMed  Google Scholar 

  23. Taborda CP, Casadevall A (2001) Immunoglobulin M efficacy against Cryptococcus neoformans: mechanism, dose dependence, and prozone-like effects in passive protection experiments. J Immunol 166(3):2100–2107

    Article  CAS  PubMed  Google Scholar 

  24. Casadevall A, Pirofski L (2011) A new synthesis for antibody-mediated immunity. Nat Immunol 13(1):21–28

    Article  PubMed  PubMed Central  Google Scholar 

  25. Albuquerque P, Casadevall A (2012) Quorum sensing in fungi – a review. Med Mycol 50(4):337–345

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Buissa-Filho R, Puccia R, Marques AF et al (2008) The monoclonal antibody against the major diagnostic antigen of Paracoccidioides brasiliensis mediates immune protection in infected BALB/c mice challenged intratracheally with the fungus. Infect Immun 76(7):3321–3328

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Gesztesi JL, Puccia R, Travassos LR et al (1996) Monoclonal antibodies against the 43,000 Da glycoprotein from Paracoccidioides brasiliensis modulate laminin-mediated fungal adhesion to epithelial cells and pathogenesis. Hybridoma 15(6):415–422

    Article  CAS  PubMed  Google Scholar 

  28. de Mattos Grosso D, de Almeida SR, Mariano M et al (2003) Characterization of gp70 and anti-gp70 monoclonal antibodies in Paracoccidioides brasiliensis pathogenesis. Infect Immun 71(11):6534–6542

    Article  PubMed  PubMed Central  Google Scholar 

  29. Thomaz L, Nosanchuk JD, Rossi DCP et al (2014) Monoclonal antibodies to heat shock protein 60 induce a protective immune response against experimental Paracoccidioides lutzii. Microbes Infect 16(9):788–795

    Article  CAS  PubMed  Google Scholar 

  30. Travassos LR, Rodrigues EG, Iwai LK et al (2008) Attempts at a peptide vaccine against paracoccidioidomycosis, adjuvant to chemotherapy. Mycopathologia 165(4–5):341–352

    Article  CAS  PubMed  Google Scholar 

  31. Benard G, Patzina RL, Schwab JB et al (2012) Fatal septic shock due to a disseminated chronic form of paracoccidioidomycosis in an aged woman. Med Mycol 50(4):407–411

    Article  PubMed  Google Scholar 

  32. Thind SK, Taborda CP, Nosanchuk JD (2015) Dendritic cell interactions with Histoplasma and Paracoccidioides. Virulence 6(5):424–432

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Magalhães A, Ferreira KS, Almeida SR et al (2012) Prophylactic and therapeutic vaccination using dendritic cells primed with peptide 10 derived from the 43-kilodalton glycoprotein of Paracoccidioides brasiliensis. Clin Vaccine Immunol 19(1):23–29

    Article  PubMed  PubMed Central  Google Scholar 

  34. Braga CJ, Rittner GMG, Henao JEM et al (2009) Paracoccidioides brasiliensis vaccine formulations based on the gp43-derived P10 sequence and the Salmonella enterica FliC flagellin. Infect Immun 77(4):1700–1707

    Google Scholar 

  35. Arnon R (1986) Synthetic peptides as the basis for future vaccines. Trends Biochem Sci 11(12):521–524

    Article  CAS  Google Scholar 

  36. Jiang S, Song R, Popov S et al (2006) Overlapping synthetic peptides as vaccines. Vaccine 24(37–39):6356–6365

    Article  CAS  PubMed  Google Scholar 

  37. Puccia R, Schenkman S, Gorin PAJ et al (1986) Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun 53(1):199–206

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Taborda CP, Camargo ZP (1993) Diagnosis of paracoccidioidomycosis by passive haemagglutination assay of antibody using a purified and specific antigen-gp43. J Med Vet Mycol 31(2):155–160

    Article  CAS  PubMed  Google Scholar 

  39. Taborda CP, Camargo ZP (1994) Diagnosis of paracoccidioidomycosis by dot immunobinding assay for antibody detection using the purified and specific antigen gp43. J Clin Microbiol 32(2):554–556

    CAS  PubMed  PubMed Central  Google Scholar 

  40. Travassos LR, Puccia R, Cisalpino P et al (1995) Biochemistry and molecular biology of the main diagnostic antigen of Paracoccidioides brasiliensis. Arch Med Res 26(3):297–304

    CAS  PubMed  Google Scholar 

  41. Puccia R, Takaoka DT, Travassos LR (1991) Purification of the 43 kDa glycoprotein from exocellular components excreted by Paracoccidioides brasiliensis in liquid culture (TOM medium). J Med Vet Mycol 29(1):57–60

    Article  CAS  PubMed  Google Scholar 

  42. Cisalpino PS, Puccia R, Yamauchi LM et al (1996) Cloning, characterization, and epitope expression of the major diagnostic antigen of Paracoccidioides brasiliensis. J Biol Chem 271(8):4553–4560

    Article  CAS  PubMed  Google Scholar 

  43. Almeida IC, Neville DCA, Mehlert A et al (1996) Structure of the N-linked oligosaccharide of the main diagnostic antigen of the pathogenic fungus Paracoccidioides brasiliensis. Glycobiology 6(5):507–515

    Article  CAS  PubMed  Google Scholar 

  44. Taborda CP, Juliano MA, Puccia R et al (1998) Mapping of the T-cell epitope in the major 43-kilodalton glycoprotein of Paracoccidioides brasiliensis which induces a Th-1 response protective against fungal infection in BALB/c mice. Infect Immun 66(2):786–793

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Marques AF, da Silva MB, Juliano MAP et al (2006) Peptide immunization as an adjuvant to chemotherapy in mice challenged intratracheally with virulent yeast cells of Paracoccidioides brasiliensis. Antimicrob Agents Chemother 50(8):2814–2819

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Muñoz JE, Luft VD, Amorim J et al (2014) Immunization with P10 peptide increases specific immunity and protects immunosuppressed BALB/c mice infected with virulent yeasts of Paracoccidioides brasiliensis. Mycopathologia 178(3–4):177–188

    Article  PubMed  Google Scholar 

  47. Perez-Riverol Y, Sanchez A, Ramos Y et al (2011) In silico analysis of accurate proteomics, complemented by selective isolation of peptides. J Proteome 74(10):2071–2082

    Article  CAS  Google Scholar 

  48. National Science Foundation (2006) Bradford protein assay protocol. 1–3

    Google Scholar 

  49. Perkins DN, Pappin DJ, Creasy DM et al (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20(18):3551–3567

    Article  CAS  PubMed  Google Scholar 

  50. Iwai LK, Yoshida M, Sidney J et al (2003) In silico prediction of peptides binding to multiple HLA-DR molecules accurately identifies immunodominant epitopes from gp43 of Paracoccidioides brasiliensis frequently recognized in primary peripheral blood mononuclear cell responses from sensitized individuals. Mol Med 9(9–12):209–219

    CAS  PubMed  PubMed Central  Google Scholar 

  51. Leo KI, Yoshida M, Sadahiro A et al (2007) T-cell recognition of Paracoccidioides brasiliensis gp43-derived peptides in patients with paracoccidioidomycosis and healthy individuals. Clin Vaccine Immunol 14(4):474–476

    Article  Google Scholar 

  52. Mayorga O, Muñoz JE, Lincopan N et al (2012) The role of adjuvants in therapeutic protection against paracoccidioidomycosis after immunization with the P10 peptide. Front Microbiol 3:154

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. GMG R, Muñoz JE, Marques AF et al (2012) Therapeutic DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis. PLoS Negl Trop Dis 6(2):1–9

    Google Scholar 

  54. de Amorim J, Magalhães A, Muñoz JE et al (2013) DNA vaccine encoding peptide P10 against experimental paracoccidioidomycosis induces long-term protection in presence of regulatory T cells. Microbes Infect 15(3):181–191

    Article  PubMed  Google Scholar 

  55. Amaral AC, Marques AF, Muñoz JE et al (2010) Poly-lactic acid-glycolic acid nanoparticles markedly improve immunological protection provided by peptide P10 against murine paracoccidioidomycosis. Br J Pharmacol 159(5):1126–1132

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Taborda CP, Nakaie CR, Cilli EM et al (2004) Synthesis and immunological activity of a branched peptide carrying the T-cell epitope of gp43, the major exocellular antigen of Paracoccidioides brasiliensis. Scand J Immunol 59(1):58–65

    Article  CAS  PubMed  Google Scholar 

  57. Lincopan N, Espíndola NM, Vaz AJ et al (2009) Novel immunoadjuvants based on cationic lipid: preparation, characterization and activity in vivo. Vaccine 27(42):5760–5771

    Article  CAS  PubMed  Google Scholar 

  58. Marques AF, da Silva MB, Juliano MAP et al (2008) Additive effect of P10 immunization and chemotherapy in anergic mice challenged intratracheally with virulent yeasts of Paracoccidioides brasiliensis. Microbes Infect 10(12–13):1251–1258

    Article  CAS  PubMed  Google Scholar 

  59. Franco L, Najvar L, Gomez BL et al (1998) Experimental pulmonary fibrosis induced by Paracoccidioides brasiliensis conidia: measurement of local host responses. AmJTrop Med Hyg 58(4):424–430

    Article  CAS  Google Scholar 

  60. Pinto AR, Puccia R, Diniz SN et al (2000) DNA-based vaccination against murine paracoccidioidomycosis using the gp43 gene from Paracoccidioides brasiliensis. Vaccine 18:3050–3058

    Article  CAS  PubMed  Google Scholar 

  61. Kurokawa CS, Lopes CR, Sugizaki MF et al (2005) Virulence profile of ten Paracoccidioides brasiliensis isolates. Association with morphologic and genetic patterns. Rev Inst Med Trop São Paulo 47(5):257–262

    Article  PubMed  Google Scholar 

  62. Camargo ZP, Taborda CP, Rodrigues EG et al (1991) The use of cell-free antigens of Paracoccidioides brasiliensis in serological tests. J Med Vet Mycol 29(1):31–38

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Fundação de Amparo a Pesquisa do Estado de São Paulo (Fapesp) for research grants and the National Research Council (CNPq) for career fellowships.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luiz R. Travassos .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Taborda, C.P., Travassos, L.R. (2017). Peptide Vaccine Against Paracoccidioidomycosis. In: Kalkum, M., Semis, M. (eds) Vaccines for Invasive Fungal Infections. Methods in Molecular Biology, vol 1625. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7104-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7104-6_9

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7103-9

  • Online ISBN: 978-1-4939-7104-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics